Umbilical cord blood transplantation
- 38 Downloads
Over the past decade umbilical cord blood has been established as a viable source of hematopoietic stem cells for allogeneic transplantation. Early experience with umbilical cord blood transplantation (CBT) demonstrated a lower incidence of graft-versus-host disease even though the procedure was performed with HLA-disparate grafts. The overall outcome of CBT appears similar to that of allogeneic bone marrow transplantation. The expansion of the donor selection is particularly beneficial to ethnic minorities, whose representation in the marrow registries is relatively small. The major drawbacks of CBT are slow hematopoietic recovery and a high incidence of graft failure, as a result of a lower number of progenitors infused. This paper reviews the current results of CBT and ongoing investigations to increase its availability to a larger number of recipients.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Rocha V, Cornish J, Sievers E, et al.: Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001, 97:2962–2971.This retrospective study compared the outcome of cord blood transplantation with that of unmanipulated and T-cell-depleted unrelated-donor marrow transplantation. Despite differences in the problems encountered among the three groups, the overall survival was similar.PubMedCrossRefGoogle Scholar
- 3.Rubinstein P, Kurtzberg J, Loberiza FR, et al.: Comparison of unrelated cord blood and unrelated bone marrow transplants for leukemia in children: a collaborative study of the New York Blood Center and the International Bone Marrow Transplant Registry [abstract]. Blood 2001, 98:814a.This comparative study showed that the degree of HLA disparity affected the outcome of children undergoing unrelated-donor cord blood and marrow transplantation. Survival with a one-HLA-antigen-mismatched cord blood transplant was similar to that with a fully HLA-identical marrow graft.CrossRefGoogle Scholar
- 6.Gluckman E, Rocha V, Arcese W, et al.: Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004, 32:397–407. A large series comparing the relative contribution of cell dose and HLA disparity in the outcome of cord blood transplantation.PubMedCrossRefGoogle Scholar
- 7.Michel G, Rocha V, Chevret S, et al.: Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord group analysis. Blood 2003, 102:4290–4297. In a retrospective study, the authors showed that unrelateddonor cord blood transplants were efficacious for advanced childhood AML.PubMedCrossRefGoogle Scholar
- 8.Gluckman E, Rocha V: Cord blood transplantation for children with acute leukemia: a Eurocord registry analysis. Blood Cells Mol Dis 2004, 33:271–273.A general overview of the results of a large cohort of children undergoing umbilical cord blood transplants for leukemia. The outcome of acute lymphoblastic leukemia was analyzed in detail.PubMedCrossRefGoogle Scholar
- 11.Kurtzberg J, Carter SL, Baxter-Lowe LA, et al.: Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of 193 unrelated donor umbilical cord blood transplantation in pediatric patients with malignant conditions [abstract]. Biol Blood Marrow Transplant 2005, 11(Suppl 1):2.CrossRefGoogle Scholar
- 12.Barker JN, Weisdorf DJ, DeFor TE, et al.: Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915–1919.A large cohort of cord blood recipients of reduced-intensity conditioning was reported. A minor variation of the preparative regimen was shown to affect the transplant outcome.PubMedCrossRefGoogle Scholar
- 15.Petropoulos D, Worth LL, Mullen CA, et al.: Total body irradiation, fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies [abstract]. Blood (ASH Annual Meeting Abstracts) 2004, 104:506a, Abstract 1827.Google Scholar
- 20.Shpall E, de Lima M, Chan KW, et al.: Transplantation of cord blood expanded ex vivo with copper chelator [abstract]. Blood (ASH Annual Meeting Abstracts) 2004, 104:281a, Abstract 982.Google Scholar
- 21.Barker JN, Weisdorf DJ, DeFor TE, et al.: Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343–1447.The first report of a significant number of patients given double cord blood transplants. The high success rate may change the approach in the treatment of heavier recipients.PubMedCrossRefGoogle Scholar
- 22.Fernandez MN, Regidor C, Cabrera R, et al.: Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003, 31:535–544.This is an entirely different concept to facilitate cord blood engraftment. Its safety and efficacy await further confirmatory studies.PubMedCrossRefGoogle Scholar